|Acquired by||GE Healthcare|
|Description||Cancer Diagnostic Testing|
|Applied Genomics, 12/2009||$17.6M|
|Venture Round, 5/2009 |
Oak Investment Partners
Clarient is a leading provider of cancer diagnostic testing. They work with local pathologists and oncologists to bring the standard of care back into their community. They’re dedicated to providing clarity to complex problems by using a number of technologies to help their clients diagnose cancer cases. They also provide them insight into what therapies will work best for these patients, and continue with follow-up and case monitoring.